Sfoglia per RIVISTA
EUROPEAN JOURNAL OF CANCER (OXFORD, ENGLAND : 1990)
Collezione AOU San Luigi di Orbassano

  

Items : 29

Response to letter to the editor on "Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma". in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2025 Mar 11;218:115277. doi: 10.1016/j.ejca.2025.115277. Epub 2025 Feb 1.

2025
AOU San Luigi di Orbassano

Scatolini M; Grisanti S; Puglisi S; Tomaiuolo P; Berruti A; Terzolo M;

A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Sep;208:114129. doi: 10.1016/j.ejca.2024.114129. Epub 2024 May 25.

2024
AOU San Luigi di Orbassano

Bongiovanni A; Liverani C; Foca F; Bergamo F; Leo S; Pusceddu S; Gelsomino F; Brizzi MP; Di Meglio G; Spada F; Tamberi S; Lolli I; Cives M; Marconcini R; Pucci F; Berardi R; Antonuzzo L; Badalamenti G; Santini D; Recine F; Vanni S; Tebaldi M; Severi S; Rudnas B; Nanni O; Ranallo N; Crudi L; Calabrò L; Ibrahim T; et alii...

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11.

2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Salerno F; Camerini A; Carta A; Follador A; Berardi R; Toschi L; Zoratto F; Cortinovis DL; Citarella F; Bulotta A; Rastelli F; Adamo V; Guida A; Manzo A; Cecere FL; Belluomini L; Roca E; Pasello G; Cerea G; Montrone M; Delcuratolo MD; Passiglia F; Guaitoli G; Bertolini F; Genova C; Caliman E; Mazzoni F; Siringo M; Gelibter A; et alii...

Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Jul;205:114088. doi: 10.1016/j.ejca.2024.114088. Epub 2024 Apr 26.

2024
AOU San Luigi di Orbassano

Scatolini M; Grisanti S; Tomaiuolo P; Grosso E; Basile V; Cosentini D; Puglisi S; Laganà M; Perotti P; Saba L; Rossini E; Palermo F; Sigala S; Volante M; Berruti A; Terzolo M;

Letter Re: Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Dec;213:115085. doi: 10.1016/j.ejca.2024.115085. Epub 2024 Oct 28.

2024
AOU San Luigi di Orbassano

Sini C; Di Federico A; Bironzo P; De Giglio A; Gelsomino F;

Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Jul;187:174-184. doi: 10.1016/j.ejca.2023.03.027. Epub 2023 Mar 30.

2023
AOU San Luigi di Orbassano

Normanno N; De Luca A; Abate RE; Morabito A; Milella M; Tabbò F; Curigliano G; Masini C; Marchetti P; Pruneri G; Guarneri V; Frassineti GL; Fasola G; Adamo V; Daniele B; Berardi R; Feroce F; Maiello E; Pinto C;

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15.

2023
ASL Cuneo 2
AO Cuneo
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Liello R; Di Maio M; Perrone F; Fabi A; Tuninetti V; Turco F; Trastu F; Reale ML; Paratore C; Lombardi P; Marandino L; Mariniello A; Ghisoni E; Gargiulo P; Bungaro M; Caglio A; Gamba T; Rossi A; Audisio M; Aimar G;

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Bria E; Rossi G; Rossi A; Di Maio M; Bareggi C; Osman G; Cortinovis D; Cappuzzo F; Del Conte A; Pilotto S; Sergi C; Gregorc V; Ghilardi L; Scotti V; Tiseo M; Martelli O; Maiello E; Rigutto A; Galetta D; Castellana S; Trombetta D; Gobbini E; Muscarella LA; Tabbò F; Volante M; Scagliotti GV; Graziano P; Novello S; Righi L; et alii...

Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Mar;163:44-54. doi: 10.1016/j.ejca.2021.12.023. Epub 2022 Jan 13.

2022
AOU Alessandria
ASL Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Dianzani I; Matullo G; Magnani C; Ferrante D; Moro L; Migliore E; Mirabelli D; Papotti M; Scagliotti GV; Giachino D; Boldorini R; Aspesi A; Pinton G; Clavenna MG; Casalone E; Allione A; Grosso F; Libener R; Muzio A; Baietto G; Parini S; Sculco M; La Vecchia M; Rena O;

2021
ASL Asti
AO Cuneo
ASL Città di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Berruti A; Tucci M; Gennari A; Baier S; Bellissimo AR; Ciccone G; Montagnani F; Comandone A; Chiappino I; Dal Canton O; Masini C; Sacco C; Zamparini M; Sirotova Z; Fea E; Valcamonico F; Vanella P; Ortega C; Buttigliero C; Prati V; Bianchi S; Mosca A; Dalla Volta A; Amoroso D;

Pericarditis during chemoimmunotherapy for non-small cell lung cancer: an adverse event to prevent and recognise. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:114-116. doi: 10.1016/j.ejca.2021.03.004. Epub 2021 Apr 12.

2021
AOU San Luigi di Orbassano

Jacobs F; Carnio S; De Stefanis P; Luciano A; Novello S;

Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:49-60. doi: 10.1016/j.ejca.2021.03.007. Epub 2021 Apr 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Perrone F; Gamba T; Caglio A; Bungaro M; Audisio M; Reale ML; Gargiulo P; Mariniello A; Di Maio M; Zichi C; Paratore C;

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Ficorella C; Addeo A; Friedlaender A; Banna GL; Di Maio M; Spinelli GP; Russo A; Adamo V; De Filippis M; Metro G; Simona C; Natalizio S; Migliorino MR; Landi L; Ricciardi S; Buti S; Minuti G; Nigro O; Cantini L; Bracarda S; Citarella F; Russano M; Filetti M; Zoratto F; Gori S; De Tursi M; Mansueto G; Rocco D; et alii...

RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:74-83. doi: 10.1016/j.ejca.2021.01.015. Epub 2021 Feb 12.

2021
AOU San Luigi di Orbassano

Malapelle U; Passiglia F; Cremolini C; Reale ML; Pepe F; Pisapia P; Avallone A; Cortinovis D; De Stefano A; Fassan M; Fontanini G; Galetta D; Lauricella C; Listì A; Loupakis F; Pagni F; Pietrantonio F; Pilotto S; Righi L; Bianchi AS; Parra HS; Tiseo M; Verzè M; Troncone G; Novello S;

Synaptophysin expression in (V600EBRAF-)mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:145-154. doi: 10.1016/j.ejca.2021.01.016. Epub 2021 Feb 16.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Loupakis F; Dei Tos AP; Di Maio M; Zagonel V; Lonardi S; Biason P; Borga C; Centonze G; Santini D; Salmaso R; Salvatore L; Aprile G; Calvetti L; Smiroldo V; Rimassa L; Cortiula F; De Maglio G; Morano F; Boccaccino A; Bergamo F; Volante M; Zichi C; Dell'Aquila E; Sperti E; Pella N; Pietrantonio F; Schirripa M; Cremolini C; Maddalena G; et alii...

D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:10-22. doi: 10.1016/j.ejca.2021.03.031. Epub 2021 Apr 19.

2021
ASL Torino 3
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ponti A; Morino M; Sasako M; Reddavid R; Tomatis M; Degiuli M;

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cortellini A; Mazzaschi G; Tiseo M; Pinato DJ; Carmisciano L; Ficorella C; Porzio G; Cannita K; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Adamo V; Russo A; Olmetto E; Metro G; Landi L; Ricciardi S; Migliorino MR; Tabbò F; Minuti G; Tuzi A; Bisonni R; Follador A; Gelibter A; Siringo M; Signorelli D; De Toma A; Garassino MC; et alii...

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jul;151:211-220. doi: 10.1016/j.ejca.2021.03.011. Epub 2021 May 19.

2021
AOU San Luigi di Orbassano

Mezquita L; Preeshagul I; Auclin E; Saravia D; Hendriks L; Rizvi H; Park W; Nadal E; Martin-Romano P; Ruffinelli JC; Ponce S; Audigier-Valette C; Carnio S; Blanc-Durand F; Bironzo P; Tabbò F; Reale ML; Novello S; Hellmann MD; Sawan P; Girshman J; Plodkowski AJ; Zalcman G; Majem M; Charrier M; Naigeon M; Rossoni C; Mariniello A; Paz-Ares L; et alii...

Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Feb;144:31-40. doi: 10.1016/j.ejca.2020.11.017. Epub 2020 Dec 13.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pietrantonio F; Morano F; Calareso G; Di Bartolomeo M; de Braud F; Vaiani M; Greco FG; Prisciandaro M; Pagani F; Palermo F; Raimondi A; Antista M; Clavarezza M; Racca P; Tomasello G; Murialdo R; Tampellini M; Zaniboni A; Smiroldo V; Antoniotti C; Bergamo F; Rimassa L; Lonardi S; Cremolini C; Randon G; Corallo S; Manca P;

KRAS inhibition in non-small cell lung cancer: Past failures, new findings and upcoming challenges. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Sep;137:57-68. doi: 10.1016/j.ejca.2020.06.023. Epub 2020 Jul 31.

2020
AOU San Luigi di Orbassano

Passiglia F; Malapelle U; Del Re M; Righi L; Pagni F; Furlan D; Danesi R; Troncone G; Novello S;

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baldessari C; Novello S; Bartoli G; Pizzutilo EG; Landi L; Dall'Olio FG; Toschi L; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Bearz A; Camerini A; Sala E; Migliorino MR; Cerea G; Ardizzoni A; Bennati C; Vita E; Del Conte A; Rossi S; Scotti V; Pilotto S; Cecere FL; Proto C; Berardi R; Mazzoni F; et alii...

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pietrantonio F; Di Bartolomeo M; Peverelli G; de Braud F; Antista M; Niger M; Bergamo F; Cinieri S; Longarini R; Giordano M; Antonuzzo L; Petrelli F; Adamo V; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Ritorto G; Sartore-Bianchi A; Rimassa L; Antoniotti C; Corallo S; Lonardi S; Morano F; Raimondi A; Di Maio M; Raimondi A; Di Maio M; et alii...

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Nov;122:109-114. doi: 10.1016/j.ejca.2019.09.012. Epub 2019 Oct 28.

2019
AOU San Luigi di Orbassano

Levy A; Hendriks LEL; Berghmans T; Faivre-Finn C; GiajLevra M; GiajLevra N; Hasan B; Pochesci A; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Besse B; Novello S; Dingemans AC;

Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Dec;123:28-35. doi: 10.1016/j.ejca.2019.09.013. Epub 2019 Oct 23.

2019
AOU San Luigi di Orbassano

Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2018 Apr;93:37-46. doi: 10.1016/j.ejca.2018.01.067. Epub 2018 Feb 21.

2018
AOU San Luigi di Orbassano

Levy A; Faivre-Finn C; Hasan B; De Maio E; Berghoff AS; Girard N; Greillier L; Lantuéjoul S; O'Brien M; Reck M; Dingemans AC; Novello S; Berghmans T; Besse B; Hendriks L;

ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2012 May;48(7):961-73. doi: 10.1016/j.ejca.2012.02.001. Epub 2012 Mar 6.

2012
AOU San Luigi di Orbassano

Scagliotti G; Stahel RA; Rosell R; Thatcher N; Soria JC;

Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2011 Apr;47(6):814-8. doi: 10.1016/j.ejca.2010.12.026. Epub 2011 Feb 18.

2011
AOU San Luigi di Orbassano

Guglielmelli T; Bringhen S; Rrodhe S; Gay F; Cavallo F; Berruti A; Montefusco V; Piro E; Benevolo G; Petrucci MT; Caravita T; Offidani M; Corradini P; Boccadoro M; Saglio G; Palumbo A;

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2009 Sep;45(13):2298-303. doi: 10.1016/j.ejca.2009.04.033. Epub 2009 May 25.

2009
AOU San Luigi di Orbassano

Scagliotti GV; Park K; Patil S; Rolski J; Goksel T; Martins R; Gans SJ; Visseren-Grul C; Peterson P;

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2005 Jan;41(2):249-55. doi: 10.1016/j.ejca.2004.07.003.

2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L;